The vaccines are usually marketed as monovalent vaccines, e.g. type A or type O, and, in some cases, it is important to know the strain of virus used in the vaccine e.g. Type O Manisa strain. This allows decisions to be made that match the most appropiate vaccine (providing the closest "antigenic homology") to the outbreak strain.